Skip to main content
. Author manuscript; available in PMC: 2015 May 28.
Published in final edited form as: Respir Med. 2015 Feb 7;109(4):526–531. doi: 10.1016/j.rmed.2015.01.019

Table 2.

Unadjusted comparison of mean scores between prednisone does groups (<500 mg/year versus >500 mg/year)*.

PRO module >500 mg prednisone/year <=500 mg prednisone/year Minimum important difference** p-Value
SHQ total [+] 4.14 (0.33) 4.18 (0.37) N/A 0.61
SHQ physical [+] 4.14 (0.70) 4.01 (0.70) N/A 0.11
SHQ daily [+] 4.42 (0.46) 4.73 (0.41) N/A 0.02
SHQ emotional [+] 3.87 (0.48) 3.79 (0.51) N/A 0.41
SAT pain [–] 54.5 (10.0) 51.76 (10.3) 3.2 0.15
SAT fatigue [–] 55.5 (11.4) 52.4 (10.5) 3.1 0.13
SAT satisfaction [+] 46.5 (10.7) 50.9 (11.4) 3.0 0.03
SAT daily activities [+] 42.1 (7.5) 45.6 (9.8) 3.0 0.03
SAT lung [–] 45.73 (9.1) 43.0 (9.6) 2.7 0.13

SHQ: Sarcoidosis Health Questionnaire; SAT: sarcoidosis assessment tool;

*

: standard deviations given in the parentheses;

**

previously established (REF# 16);

[+]: higher score indicates better quality of life; [–]: lower score indicates better quality of life; N/A: not applicable as minimum important difference has not been determined for the Sarcoidosis Health Questionnaire.